Summary. Immunoreactive insulin (11%1) release from collagenase isolated pancreatic islets of spiny mice (Acomys cahirinus) was examined in 15 rain and 2 h incubations at glucose concentrations between 2.8 and 56 mlVi. The resultant glucose-insulin dose-response curves for Acomys islets were compared to those for similarly incubated rat. islets. After 15 mill incubations, IgI release from Acomys islets was significantly lower than that from rat islets at all stimulating glucose concentrations. After 2 h incubations, however, maximal responses were similar for Acomys and rat islets, whereas the sensitivity of Aeomys islets to glucose was significantly less. Cyclic AMP 10 raM, theophylline 5 raM, arginine 10 raM, and cytochalasin B 10 Exg/ml, all enhanced IRI release in the presence of glucose 16.7 mM to a relatively greater extent from Acomys than from rat islets. Vineristine 10-SM reduced II~I release from both Acomys and rat islets, and this to a similar extent. The results suggest that defective IRI release from Acomys islets may be the expression of decreased B-cell sensitivity to glucose, even though Ii~I release from Acomys islets may improve in time with continued exposure to elevated glucose concentrations.
Introduction
The pancreas of the rodent Acomys cahirinus of the Geneva colony is characterized histologically by marked hyperplasia of the islets of Langerhans. The immunoreactive insulin (Ii~I) content of the pancreas is correspondingly elevated [10, 13, 23] . Nevertheless, in vivo studies in the Acomys have demonstrated that Il~I response $o insulinotropic agents is slower and smaller [2, 3, 11] than in other rodents. The purpose of the experiments with collagenase isolated islets reported here was to assess whether the low Il~I responses observed in vivo could also be demonstrated in vitro.
Materials and Methods

Animals
Thirty-one 2--3 month old male Acomys were used. Bred in our laboratory, they were fed ad libitum and weighed 28 to 44 g; at decapitation their plasma glucose was 152 4-4 rag/100 ml. 
Experimental Procedures
Islets were isolated using collagenase according to Lacy et el. [15] either from a single Acomys pancreas, or from pancreata pooled from two rats. 10 islets were placed into each incubation flask, contain~g 1 ml Idrebs-l~inger bicarbonate buffer with bovine serum albumin 5 mg/ml and Trasylol 500 units/ml, kindly provided by Dr. tI. l~uef, Bayer Pharma, A.G., Zurich. The flasks were incubated for 15 rain or for 2 h in a Dubnoff shaking incubator at 37~ and the atmosphere above the open flasks was continuously gassed with 0JC0~:93/7. Each different condition or agent was tested in at least 5 flasks in a given experiment.
Measurements
Insulin (IRI) released into the medium was determined by the charcoal separation radioimmunoassay method of Herbert ct el. [12] . Islet IRI content was also measured on groups of 10 islets (not incubated) using acid-ethanol extraction according to Scott and Fisher [21] . IRI of Acomys was assayed using anti-beef insulin antibody and sheep insulin standard [2] while rat. Ii~I was measured using anti-pork insulin antibody and rat insulin standard. The antibodies were kindly donated by Dr. Peter Wright, Indianapolis, Indiana, and the insulin standardq by Dr. J. Schlichtkrult, Novo Industri, Kopenhagen, Denmark. Islet ATP content was assayed by the lueiierin-luciferase method of Kilbert et al. [14] . For statistical evaluation Student's unpaired t-test was used.
Reagents and Chemicals
Theophylline and arginine hydroehloride were purchased from Merck and Co., Darmstadt, Germany; adenosine 3',5'-cyclic monophosphate (cyclic AMP), dimethylsulfoxide (DMSO) and perchloric acid from Fluka A.G., Buchs, Switzerland; cytochalasin B from Imperial Chem. Industries, Macclesfield, England; crude collagenase from Worthington Chem., New Jersey; firefly lantern extract from Sigma Chemical Corporation, St. Louis, Missouri; z~'sI-insulin from Cambridge ~Tuclear, Massachusetts; bovine serum albumia cantly different from that of rat islets (289 • 17 ng/ 10 islets, n = 34), although the number of islets isolated from any one Acomys pancreas was approximately double that isolated from any one rat pancreas. The similarity of islet IRI content permitted the use of equal numbers of islets from each species (10 per vial) in the secretion studies described below.
Glucose Dose-Response Studies
In order to characterize the dose relationships for the early and late IRI responses, islets were incubated Vineristine sulfate, lot NDC 2-N55-A (Oncovin, Eli Lilly), was a gift from Schweiz. Serum-und Impfinstirut, Bern, Switzerland.
Results
Insulin Content of the Islets
The acid-ethanol extractable IRI content of Acomys islets (299=E 10 ng/10 islets, n= 88) was not signoriin the presence of different concentrations of glucose, either for 15 rain (reflecting mainly the early response) or for 2 h (mainly the late response). Fig. 1 shows the glucose-IRI dose-response curves during the 15 rain incubations for each species. The lowest glucose coneentration which resulted in significant stimulation of IRI release above basal levels was 11.2 mM for Acomys islets (p < 0.05 vs. basal release), and 8.4 mM for rat islets (p < 0.01). For both species the plateau of maximal release was reached at 16.7 m~I (the higher levels noted at 28.0 mM glucose for rat islets were not signifi-
cantly different from the values at 16.7 or 56.0 raM). Also, the glucose concentration inducing haK-maximal insulin release was similar in both species (around 10 raM). Thus, during a short incubation (15 min), Acomys islets exhibited a higher threshold for glucose and significantly lower rates of insulin release at all stimulating glucose levels by comparison with rat islets (p < 0.01).
The insulin release responses observed during 2 h of incubation are shown in Fig. 2 . Again, the threshold glucose concentration eliciting I1~I release above basal levels was higher for Acomys islets (8.4 mM, p < 0.05 vs. basal release) than for rat islets (5.6 raM, p < 0.01). The maximal II~I response of Acomys islets to glucose, however, was similar to that of rat islets, although this maximal response was observed at 28 mSi glucose for Acomys, as compared to 16.7 mlV[ for rat islets. Halfmaximal response was seen at about 12.0 mM glucose for Acomys islets and 9.5 mM for rat islets. Thus, over 2 h of incubation, the glueose-IgI dose, response curve for Acomys islets was shifted to the right of that for rat islets, still indicating a decreased sensitivity of the Acomys islets to glucose, even though the maximal response reached did not differ from that of rat islets.
Enhancement of the Late Insulin Response by Agents
Other than Glucose
The effect of some agents known to enhance the insulin response to glucose was evaluated in islets incubated for 2 h in the presence of either low (2.8 mM) or high (16.7 mM) glucose ( Table 1 ). The islets used for comparison between different experimental conditions were obtained from the same collagenase isolation batch. Cyclic AMP (10 mM) did not modify the response to glucose 2.8 mM in either species, nor did it significantly increase the IRI response to glucose 16.7 mM in rat islets (+14%, NS). However, it augmented significantly the IgI release at high glucose concentration in Acomys islets (+ 90%, p < 0.01). Theophylline 5 m~, an agent that raises the intraeellular concentration of cyclic AMP [1] , had no effect on IgI release at glucose 2.8 mM, but enhanced the I1~I secretion at glucose 16.7 mMin both species, the effect being greater in Acomys islets (+68%, p<0.01) than in rat islets (+31%, p<0.05). Arginine 10 mM had similar pronounced effects on IgI release at glucose 2.8 mM in both species (+300%, p < 0.001). In the presence of glucose 16.7 mM it stimulated Acomys islets (+39%, p < 0.001) to a greater extent than rat islets (+ 18 %, NS). Cytochalasin B, an agent known to affect the microfilamentous system and to enhance glucose-induced Ii~I release [17, 24] had no effect on basal IRI release, but augmented the response to high glucose in both species. Again, the effect was greater in Acomys islets (+82%, 1o<0.001) than in rat islets (+40%,
Effects of Vincristine (Fig. 3) . All iucubations were carried out at glucose 16.7 mYI for 2 h. Vincristine, at the concentration of 10-~M, slightly but significantly reduced the stimulating effect of glucose 16.7 mM on IRI release by islets of both species (--25 to --30%, p < 0.05). Increasing the concentration to 10-aM did not reduce IRI release any further, but significantly decreased islet ATP levels, again in both species (~ 25 to--30~o, p < 0.01). 
Discussion
The results presented in this report show clearly that the low insulin responses observed in vivo in Acomys [2, 3, 11] are also to be seen in vitro. This decreased responsiveness is thus not likely to be due to modifications in the metabolism of the hormone but may well be a characteristic of the pancreatic B-cells of Acomys. Whether the choice of the rat as the control animal was appropriate or not is, of course, open to question. However, since the islets of these two species contain similar amounts of insulin, in spite of the marked differences in body size of their hosts, this comparison appears justified. The striking finding in this comparison is the difference between the two species in their respective glucose-insulin dose response relationship. Both regarding the early (15 rain) and prolonged (2 h) insulin responses, sensitivity of the Acomys islet was less, as evidenced by the higher glucose "threshold" values needed to induce stimulation of insulin release. By contrast, whereas the maximal Acomys response at 15 rain was much smaller than that of rat islets, after 2 h the islets of both species reached comparable maximal rates of release (albeit at different glucose levels). Thus, in the present in vitro system, while both the early and the late phase insulin responses of Acomys islets exhibited decreased sensitivity to glucose (as compared to the sensitivity of rat islets), decreased capacity (i.e. a low maximal response) was observed only for the early insulin release phase.
Observations in man [8] may suggest an explanation for the augmentation in maximal response seen during prolonged incubation of Acomys islets with glucose.
It was shown that glucose, with time, enhances markedly its own effect on insulin release. Applying these concepts to the insulin response of Acomys, the data available support the hypothesis of impaired ability to recognize glucose as an initiating signal, while recognition o~the time-related enhancing action of the sugar may be intact. Support for this interpretation derives from the observation that all agents which have been tested because of their known enhancing action on glucose-induced I~I release were effective in islets of Acomys, indeed more effective than was true for islets from rats, when considering the prolonged (two hours) incubations. The agents tested were cyclic AMP, theophylline, arginine and cytochalasin B. The point to be emphasized here is the presence of at least normal enhancement by agents other than glucose, not the still tentative demonstration of a greater than normal one. Before accepting the latter observation the comparison with rat islets will have to be carried out under a range of different experimental conditions, since the present one may not be optimal for the demonstration of enhancement in islets from rats. It may nevertheless be concluded that Acomys islets do not show impairment in the recognition of agents which modulate the effects of glucose.
The cause of the lower insulin release from the Bcells of Acomys in response to glucose remains obscure.
Several possibilities have been discussed previously [20] one of them being that suggested by MalaisseLagae et al. [18] who demonstrated that the number of Vincristine.indueed crystals was much less in Acomys B-cells than in those of other rodents. A possible interpretation of that observation is that a deficiency of the microtubular system might be involved in producing the characteristic insulin release pattern of Acomys.
The results reported here with vincristine neither support nor invalidate this view, as sensitivity of insulin release to vincristine was similar in Acomys and rat islets; toxic effects of the drugs, in terms of decrease in ATP, also occurred at equal concentrations in both species, thereby suggesting that the penetration of vincristine across the B-cell membrane was not altered. In closing, a brief discussion of purely speculative nature may be in order. The insulin release pattern observed in Acomys appears to resemble that observed at various stages of the diabetic syndrome in man [4, 19, 22] . Decreased insulin response to glucose administration, much more marked for the initial response phase, is frequently found in subjects with latent or chemical diabetes as well as in patients with maturityonset diabetes. The same pattern, and again it is the pattern seen in Acomys as well, has been described in a number of subiects with entirely normal glucose tolerance in whom, however, the probability to develop diabetes at a later stage is greater than for the general population [7] . In the studies referred to in man, decreased sensitivity to glucose in terms of insulin release, as in the present study, was demonstrated [6] . Furthermore, the enhancing effect oi agents such as theophylline [5] or arginine [9] was either intact or augmented in the subjects exhibiting a decreased insulin response to glucose alone. Despite all the qualifications which must be kept in mind before information obtained in one species may be transferred to another, the results described in this report clearly encourage us in continued attempts to analyze Acomys as completely as possible, as one possible model for some aspects of diabetes-relatedendocrine function.
